Diagnosis
Sarcoidosis
An idiopathic, multisystem, noncaseating granulomatous inflammatory disease that usually affects the lungs but may also involve the joints, skin, eyes, heart, and central nervous system.
Also known as: Besnier-Boeck-Schaumann disease, Boeck sarcoid, Darier-Roussy sarcoid and lymphogranulomatosis, Schaumann's disease
Etiology
Cause [3ar]
Unknown etiology
Associations to antigens: beryllium, dust, agents causing asthma
Associations to infections: mycobacteria and propionibacteria
Associations to genetics: MHC (DR alleles)
Pathophysiology
T-cells, B-cells, cytokines and tumor necrosis factor --> cellular immune reaction
Inverted CD4/CD8 ratio --> noncaseating granulomas in organs
Clinical manifestations:
Lungs: Cough, dyspnea, reduced vital capacity, hilar lymphadenopathy
Dermatologic: Maculopapulonodular subcutaneous lesions, Erythema nodosum
Ocular involvement: Uveitis
Cardiac: Cardiomyopathy, heart failure, conduction defects (arrhythmia)
Kidney: Renal calculi
CNS (neurosarcoidosis): Hearing loss, seizure, psychiatry, diabetes insipidus, hyperprolactinemia
Other: Fever, polyarthralgia, lymphadenopathy
Complications [3ar]
Pulmonary hypertension
End-stage lung disease
Epidemiology
Incidence per 100.000 [sha][c7a][a8a][mn5][n4c][v6v][dth]
Symptoms & findings
Symptoms
Anorexia, Anosmia, Arrhythmia, Arthralgia, Blurred vision, Cardiac arrest, Cough, Dyspnea, Epistaxis, Erythema nodosum, Fatigue, Fever, Hearing loss, Hemoptysis, Lymphadenopathy, Malaise, Nasal congestion, Nasal discharge, Post-nasal drip, Pruritus, Rhinorrhea, Saddle nose deformity, Seizure, Sneezing
Clinical findings
Elevated Angiotensin-Converting Enzyme, Elevated CD4/CD8-ratio, Mediastinal lymphadenopathy, Non-necrotizing granuloma, Uveitis
Anamneses
None listed.
Localized findings
Approach
Blood test: Anemia, leukopenia, thrombocytopenia, liver function tests, blood urea nitrogen, creatinine, glucose, electrolytes, hypercalcemia [3ar]
Serelogy: ACE-inhibitor, adenosine deaminase, serum amyloid A, and soluble interleukin-2 receptor [cc4][3ar]
Spirometry: reduced vital capacity, functional residual capacity, dynamic lung compliance, DLCO
Broncho Alveolar Lavage (BAL): CD4:CD8 ratio
Chest X-ray
CT thorax
PET-CT
MRI caput
Tissue biopsy
Radiographic Stages [3ar]
Stage I: Presence of bilateral hilar adenopathy
Stage II: Bilateral hilar adenopathy and reticular opacities
Stage III: Reticular opacities with shrinking hilar nodes (mainly infiltrates)
Stage IV: Reticular opacities with fibrosis
Treatment
The management depends on the course of the disease and many experience spontaneous remission within 6 months after diagnosis. [cc4]
NSAIDs for the treatment of arthralgias [l9w]
Steroid treatment: IV methylprednisolone or oral prednisone: 2 mg/kg/day
Steroid-resistant disease: [l9w]
Methotrexate
Chloroquine
Cyclophosphamide
Azathioprine
Chlorambucil
Cyclosporine
Infliximab
Thalidomide
Lung transplantation
Differential diagnoses
Acute invasive fungal sinusitis, Acute sinusitis, Allergic rhinosinusitis, Allergy, Arteriosclerosis, Cat scratch disease, Chronic sinusitis, Eosinophilic granuloma, Fungal infection, Leprosy, Lung cancer, Lymphoma, Pneumonia, Pneumonitis, Portal hypertension, Primary biliary cirrhosis, Tuberculosis, Uveitis, Wegener's granulomatosis
References
[1] Bokhari SRA, Zulfiqar H, Mansur A. Sarcoidosis. [Updated 2023 Jun 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430687/
[2] Bechman K, Biddle K, Russell M, Gibson M, adas m, Yang Z, Alveyn E, Nagra d, Norton S, biring S, Galloway J. The Incidence and Prevalence of Sarcoidosis in England [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9).
[3] Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr 2004; 93: 30–36.
[4] Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008 Feb;31(2):372-9.
[5] Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997 Feb 1;145(3):234-41.
[6] Dumas O, Abramovitz L, Wiley AS, Cozier YC, Camargo CA Jr. Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women. Ann Am Thorac Soc. 2016 Jan;13(1):67-71.
[7] Fernández-Ramón R, Gaitán-Valdizán JJ, Sánchez-Bilbao L, Martín-Varillas JL, Martínez-López D, Demetrio-Pablo R, González-Vela MC, Cifrián J, Castañeda S, Llorca J, González-Gay MA, Blanco R. Epidemiology of sarcoidosis in northern Spain, 1999-2019: A population-based study. Eur J Intern Med. 2021 Sep;91:63-69.
[8] Hena KM. Sarcoidosis Epidemiology: Race Matters. Front Immunol. 2020 Sep 15;11:537382.
[9] Clément, A., Epaud, R., & Fauroux, B. (2005). CHAPTER 16 Sarcoidosis in children.
[10] http://emedicine.medscape.com/article/301914 (2014-01-02); [Medscape]